Investors urge science-based targets to combat superbugs
livemint.com — September 3, 2024, 12:00 AM UTC
Summary: Investors managing over $13 trillion are urging global policymakers to establish science-based targets to combat antimicrobial resistance (AMR), which claims nearly 1.3 million lives annually. The initiative, backed by 80 institutions, highlights AMR's potential to incur $1 trillion in healthcare costs and 10 million deaths by 2050. The call parallels efforts to address climate change, emphasizing the need for coordinated action and data-driven strategies.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.